MEDNAX

Pediatrix Medical Group, Inc. engages in the provision of physician services. It includes newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care. The company was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

MEDNAX reports stable Q4 performance, eyes in-network growth opportunities

MEDNAX's Q4 call highlighted stable performance, strategic focus on core areas, and challenges from R1 transition and labor inflation. Opportunities in payer relationships, acquisitions, and organic growth are key for future success.

MEDNAX (MD) reports solid Q1 performance, eyes growth opportunities

MEDNAX's Q1 2023 performance showcased stability in patient volumes, pricing strength, and effective cost management. The company's focus on revenue cycle management and debt reduction yielded positive outcomes. Addressing challenges and seizing growth opportunities will be key for sustained success.

MEDNAX (MD) reports strong Q2 performance and eyes growth opportunities

MEDNAX (MD) delivers a solid performance in Q2 2023 with stable patient volumes, strong pricing, and cost efficiencies. The company's focus on improving AR collections, expanding clinics, and potential acquisitions positions it well for future growth.

MEDNAX reports Q3 earnings below forecast, revises full-year outlook

MEDNAX acknowledges disappointing Q3 results, plans structural changes to address challenges, and revises full-year adjusted EBITDA outlook. Despite facing operational challenges, the company shows strength in managing cash and negotiating subsidies with hospital partners.

MEDNAX meets Q4 expectations, eyes stable growth and cost efficiencies

MEDNAX's Q4 performance met expectations, with a focus on stabilizing margins and narrowing financial performance range. The company is poised for stable revenue growth in 2024, with opportunities to deploy capital for acquisitions and improve cost efficiencies. Challenges include stabilizing margins and addressing modest revenue growth expectations.

MEDNAX reports strong Q1 results, accelerates restructuring for growth

MEDNAX's Q1 performance reflects positive revenue growth and operational efficiency initiatives. While facing challenges in communicating practice exits and financial impacts, the company is well-positioned to capitalize on growth opportunities in core services. By focusing on restructuring and maintaining financial discipline, MEDNAX aims to drive continued progress throughout 2024.

MEDNAX surpasses Q2 expectations, focuses on strategic realignment for growth

MEDNAX's Q2 performance exceeded expectations with revenue growth and cost efficiencies driving results.
While facing challenges from restructuring, the company aims to capitalize on opportunities for margin improvement.
Maintaining financial outlook, appointing new leadership, and strategic shifts position MEDNAX for future growth.
Overall, MEDNAX's focus on operational enhancements and strategic realignment bode well for its financial health.

MEDNAX surpasses Q3 expectations with strategic initiatives driving growth

MEDNAX delivered strong Q3 performance with revenue growth, stable patient volumes, and successful operational transitions.
Strategic initiatives like portfolio restructuring and improved liquidity position highlight the company's focus on long-term sustainability.
While challenges like executing restructuring plans and managing liquidity exist, opportunities for growth and value creation are also present.
Overall, MEDNAX's financial outlook remains positive, supported by operational efficiency and prudent financial management.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax 2022 First Quarter Conference Call/Webcast Scheduled for Thursday, April 28, 2022

Mednax 2022 First Quarter Conference Call/Webcast Scheduled for Thursday, April 28, 2022

Centennial Resource Development

Embraer

Lately, opportunities for near-term gains have popped up more frequently with market volatility producing some larger than normal candlesticks. Let's look at three swing trade ideas that offer particularly good upside.

3 Swing Trades With Good Upside

Sonicshares Global Shipping ETF

Proshares Online Retail ETF

VanEck Vectors Semiconductor ETF

Simplify Volt RoboCar Disruption and Tech ETF

Technology Select Sector SPDR Fund

Meme stocks are those that hog attention of retail traders due to the hype surrounding them on online forums like Reddit. These stocks and ETFs could be played in order to tap the latest Reddit frenzy.

Beyond MEME, 5 ETFs to Play Latest Reddit Craze

Growing revenues, numerous acquisitions, diversified care network and adequate cash generation abilities are likely to continue driving Mednax (MD).

Is it the Right Time to Add Mednax (MD) Stock to Your Kitty?

Is MEDNAX (MD) a great pick from the value investor's perspective right now? Read on to know more.

Should Value Investors Consider MEDNAX (MD) Stock Now?

HCA Healthcare

Tenet Healthcare

Universal Health Services

Rising patient volumes and the growing aging population are driving Zacks Medical-Hospital industry players' profits. HCA Healthcare, Universal Health, Tenet Healthcare and Mednax are poised to benefit from improving operating efficiency.

4 Stocks to Watch From the Flourishing Hospital Industry

Mednax (MD) bringing some of its operations under the Pediatrix brand is expected to collectively promote its wide range of healthcare services.

Here's How Mednax (MD) Can Gain By Adopting the Pediatrix Brand

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- #children--Mednax's affiliated practices will adopt the Pediatrix® brand, reflecting its role as the leading provider of care for women, babies and children.

Mednax-Affiliated Practices to Adopt Pediatrix® Brand

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- #neonatology--Mednax and its Pediatrix-affiliated practices will host two premier meetings in neonatal medicine March 1-6 in San Diego.

Pediatrix® to Host Premier Neonatology Meetings March 1-6

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax to Present at 2022 J.P. Morgan Global High Yield and Leveraged Finance Conference

Mednax to Present at 2022 J.P. Morgan Global High Yield and Leveraged Finance Conference

Mednax's (MD) Q4 results improve on better revenues and expanded patient volumes.

Mednax's (MD) Q4 Earnings Surpass Estimates, Increase Y/Y

MEDNAX, Inc. (MD) CEO Mark Ordan on Q4 2021 Results - Earnings Call Transcript

Mednax (MD) delivered earnings and revenue surprises of 18.18% and 3.01%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Mednax (MD) Beats Q4 Earnings and Revenue Estimates

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax to Present at SVB Leerink 11th Annual Global Healthcare Conference

Mednax to Present at SVB Leerink 11th Annual Global Healthcare Conference

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax Reports Fourth Quarter Results

Mednax Reports Fourth Quarter Results

Mednax (MD) issues senior notes, and a new revolving credit facility coupled with a term loan remains in place, which is aimed at reducing MD's debt level and associated interest expenses.

Mednax (MD) Pursues $1.1B Transactions to Reduce Debt Burden

Mednax's (MD) fourth-quarter results are likely to reflect growth in same-unit revenues and NICU days.

Mednax (MD) to Post Q4 Earnings: Here's What You Need to Know

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax Announces Closing of $1.1 Billion in Financing Transactions

Mednax Announces Closing of $1.1 Billion in Financing Transactions

Mednax (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Mednax (MD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Mednax (MD) purchases Night Lite Pediatrics, LLC in Orlando to enhance its pediatric business line.

Mednax (MD) Buys Night Lite Pediatrics to Boost Portfolio

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax 2021 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 17, 2022

Mednax 2021 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 17, 2022

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Mednax and its affiliated practices operating as Pediatrix® Medical Group today announced the acquisition of Night Lite Pediatrics, LLC.

Pediatrix® Expands Presence in Florida Through Affiliation with 13-Clinic Pediatric Urgent Care Practice

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax Prices Private Offering of $400 Million Senior Notes Due 2030

Mednax Prices Private Offering of $400 Million Senior Notes Due 2030

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax Launches Private Offering of $400 Million Senior Notes Due 2030

Mednax Launches Private Offering of $400 Million Senior Notes Due 2030

Banking on its strategic measures and a streamlined business, Mednax (MD) holds potential to reap benefits for investors.

News for MEDNAX Stock (MD)